InvestorsObserver
×
News Home

Is Assembly Biosciences Inc (ASMB) a Bad Choice in Biotechnology Tuesday?

Tuesday, June 21, 2022 10:05 AM | InvestorsObserver Analysts

Mentioned in this article

Is Assembly Biosciences Inc (ASMB) a Bad Choice in Biotechnology Tuesday?

Assembly Biosciences Inc (ASMB) is near the top in its industry group according to InvestorsObserver. ASMB gets an overall rating of 85. That means it scores higher than 85 percent of stocks. Assembly Biosciences Inc gets a 99 rank in the Biotechnology industry. Biotechnology is number 36 out of 148 industries.

Overall Score - 85
ASMB has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on ASMB!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 85 means the stock is more attractive than 85 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Assembly Biosciences Inc Stock Today?

Assembly Biosciences Inc (ASMB) stock is trading at $2.09 as of 10:05 AM on Tuesday, Jun 21, an increase of $0.09, or 4.5% from the previous closing price of $2.00. The stock has traded between $2.02 and $2.10 so far today. Volume today is low. So far 57,221 shares have traded compared to average volume of 570,627 shares. Click Here to get the full Stock Report for Assembly Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App